U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538908) titled 'Superselective Renal Artery Embolization for Renal Angiomyolipoma' on April 13.
Brief Summary: To evaluate the efficacy and safety of selective endovascular embolization in the treatment of renal angiomyolipoma (AML). Materials and Methods: A prospective analysis will be conducted on patients who undergo transcatheter renal artery embolization for renal angiomyolipoma. Inclusion criteria will be radiologically confirmed angiomyolipoma based on CT and/or MRI findings and the presence of clinical indications for embolization. The primary outcomes will include the assessment of changes in serum creatinine and hemoglobin levels post-pr...